Neil Stahl - Dec 3, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil Stahl
Stock symbol
REGN
Transactions as of
Dec 3, 2021
Transactions value $
-$18,858,197
Form type
4
Date filed
12/6/2021, 03:10 PM
Previous filing
May 18, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -4.61K -13.78% $0.00 28.8K Nov 29, 2021 Direct
transaction REGN Common Stock Options Exercise $13M +72.5K +251.66% $179.13 101K Dec 3, 2021 Direct
transaction REGN Common Stock Tax liability -$31.8M -50.4K -49.7% $632.45 51K Dec 3, 2021 Direct
transaction REGN Common Stock Gift $0 +4.61K $0.00 4.61K Nov 29, 2021 by Spouse as Trustee
holding REGN Common Stock 5.79K Dec 3, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -72.5K -100% $0.00* 0 Dec 3, 2021 Common Stock 72.5K $179.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.